AbbVie- Big Gains In Small Molecule Drugs

AbbVie is a cutting-edge company specializing in small molecule drugs; the company has grown into the eighth-largest pharmaceutical company in the world. The stock is cheap. ABBV is selling about 30% below the 2018 high.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.